相关实验视频

Updated: Jun 3, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

对海洋天然产品作为潜在的抗糖尿病剂的计算洞察力,以SIK2蛋白激酶域为目标

K Heyram¹, J Manikandan¹, D Prabhu²

¹Structural Biology and Biocomputing Lab, Department of Bioinformatics, Alagappa University, Karaikudi, India.

SAR and QSAR in environmental research

|January 8, 2025

概括

海洋天然产品显示出作为糖尿病 (DM) 的新治疗方法的希望. 研究人员确定了针对SIK2酶的五种化合物,为数百万受DM影响的人提供了潜在的新治疗途径.

科学领域:

药用化学医学化学
计算生物学计算生物学
药理学药理学是指药理学的学科.

背景情况:

糖尿病 (DM) 影响超过7700万印度成年人,目前的治疗方法不足.
对于管理DM的新型治疗策略,存在着大量未满足的需求.
SIK2被确定为参与DM病理生理学的关键酶.

研究的目的:

研究海洋天然产品 (MNPs) 作为潜在的治疗剂,向DM的SIK2酶.
使用计算方法从大量的MNP库中识别新型SIK2抑制剂.

主要方法:

使用计算技术验证了预测SIK2酶模型的结构稳定性.
根据SIK2模型对超过38,000名MNP进行了基于结构的虚拟选 (SBVS).
利用分子动力学模拟 (MDS) 和基于主要组件 (PC) 的自由能量景观 (FEL) 分析来评估结合稳定性和亲和力.

主要成果:

确定了五个有前途的MNP候选人 (CMNPD21753,CMNPD13370,MNPD10685,SWMDRR053,SWMDRR052) 具有高的对接和MMGBSA绑定分数.
这些化合物表现出有利的预测药理动力学和毒性概况.
与已知的抑制剂 (ARN-3236) 相比,MDS和FEL分析证实了鉴定的MNP与SIK2的结合更强,更稳定.

结论:

已识别的MNP显示出作为糖尿病治疗新型SIK2抑制剂的显著潜力.
这些计算发现为未来的体外和体内实验验证提供了坚实的基础.
这项研究强调了MNP在代谢疾病的药物发现中的价值.

关键词:

DFT计算方法的计算方法糖尿病是一种糖尿病.自由能源的景观.海洋天然产品海洋自然产品分子动力学模拟模拟主要组件分析的主要组件分析

更多相关视频

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...